HomeOwner SearchCategory Search
Visit USCOTherapeutic Innovation & Regulatory Science [Published: 2018-07-19. Issue: vol. 52, no. 4, July 2018]
Serial Registration
Copyright Title
Therapeutic Innovation & Regulatory Science [Published: 2018-07-19. Issue: vol. 52, no. 4, July 2018]
Status
Published
on 30 Aug 2018
Year of Creation
2018
Copyright Claimant
Drug Information Association (DIA)
Registration Number
TX0008631004
on 30 Aug 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008631004) dated 30 Aug 2018, pertains to an electronic file (eService) titled "Therapeutic Innovation & Regulatory Science [Published: 2018-07-19. Issue: vol. 52, no. 4, July 2018]" created in 2018. The copyright holder is Drug Information Association (DIA), known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Drug Information Association (DIA).
Application Details
Registration Number
TX0008631004
Registration Date
8/30/2018
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Drug Information Association (DIA)
First Publication Nation
United States
ISSN
2168-4790
Preexisting Material
text
Notes
Copyright Local Holdings: vol. 52, no. 4, July 2018 Created 2018 Pub. 2018-07-19 Reg. 2018-09-10 TX0008631004 STEK
Material Matter Claimed Note: compilation
Statements
Application Title Statement: Therapeutic Innovation & Regulatory Science
Author Statement: Drug Information Association (DIA) employer for hire Domicile: United States Citizenship: United States Authorship: Collective Work Authorship
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.